Medicine Description avipiravir 200 mg
avipiravir 200 mg tablets is a medication that acts as an antiviral agent through the inhibition of viral RNA polymerase. It is a prodrug that is converted into its active form inside the body, leading to the disruption of viral replication. Favipiravir specifically targets the RNA-dependent RNA polymerase, a crucial enzyme for the replication of RNA viruses, including influenza virus and SARS-CoV-2. By interfering with the viral replication process, avipiravir effectively reduces the viral load in infected individuals, thereby mitigating the severity of the disease and promoting recovery.
Indications and Uses of avipiravir 200 mg tablets
- Treatment of influenza virus infections
- Management of COVID-19 in certain patient populations
Side Effects of avipiravir 200 mg tablets
- Nausea
- Diarrhea
- Elevated liver enzymes
- Fatigue
- Headache
Storage and Handling
Store avipiravir 200 mg tablets at room temperature, away from direct light and moisture. Keep this medication out of reach of children and do not use it after the expiration date on the packaging.
Patient Advice and Precautions
Patients should be advised to inform their healthcare provider of any pre-existing conditions, particularly liver disease, before starting treatment with avipiravir. It is essential to monitor for potential side effects, especially gastrointestinal symptoms. Pregnant or breastfeeding women must consult their healthcare provider due to potential risks. Adherence to the prescribed treatment regimen is vital for effectiveness.